Literature DB >> 1367778

Use of high density cultures of Escherichia coli for high level production of recombinant Pseudomonas aeruginosa exotoxin A.

R Fass1, M van de Walle, A Shiloach, A Joslyn, J Kaufman, J Shiloach.   

Abstract

An efficient fermentation method for the production of two modified recombinant Pseudomonas aeruginosa exotoxin As cloned in Escherichia coli BL21(lambda DE3) was developed. Cell densities of 16-30 g dry weight/1 were found to be most suitable for the induction of protein synthesis, which was under the isopropyl beta-D-thiogalactopyranoside (IPTG)-inducible T7 expression system. A concentration of 0.6 mM IPTG and induction time of 90 min were found to give the best results for production of the modified toxins. Using this procedure, gram amounts of the proteins were obtained in a 3-1 bench-top fermentor. The high density growth of the bacteria did not impair the integrity of the proteins and did not interfere with the purification procedure.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1367778     DOI: 10.1007/BF00164700

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   5.560


  12 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Enzymatically active peptide from the adenosine diphosphate-ribosylating toxin of Pseudomonas aeruginosa.

Authors:  D W Chung; R J Collier
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

4.  Effects of medium quality on the expression of human interleukin-2 at high cell density in fermentor cultures of Escherichia coli K-12.

Authors:  H L MacDonald; J O Neway
Journal:  Appl Environ Microbiol       Date:  1990-03       Impact factor: 4.792

5.  Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes.

Authors:  F W Studier; B A Moffatt
Journal:  J Mol Biol       Date:  1986-05-05       Impact factor: 5.469

6.  Use of a novel air separation system in a fed-batch fermentative culture of Escherichia coli.

Authors:  R Fass; T R Clem; J Shiloach
Journal:  Appl Environ Microbiol       Date:  1989-05       Impact factor: 4.792

7.  Toxoid of Pseudomonas aeruginosa exotoxin A generated by deletion of an active-site residue.

Authors:  M Lukac; G B Pier; R J Collier
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.609

8.  Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli.

Authors:  J Hwang; D J Fitzgerald; S Adhya; I Pastan
Journal:  Cell       Date:  1987-01-16       Impact factor: 66.850

9.  Antitumor activity in mice of an immunotoxin made with anti-transferrin receptor and a recombinant form of Pseudomonas exotoxin.

Authors:  J K Batra; Y Jinno; V K Chaudhary; T Kondo; M C Willingham; D J FitzGerald; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 12.779

10.  Role of domain II of Pseudomonas exotoxin in the secretion of proteins into the periplasm and medium by Escherichia coli.

Authors:  V K Chaudhary; Y H Xu; D FitzGerald; S Adhya; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 12.779

View more
  11 in total

1.  High-level production of human leptin by fed-batch cultivation of recombinant Escherichia coli and its purification.

Authors:  K J Jeong; S Y Lee
Journal:  Appl Environ Microbiol       Date:  1999-07       Impact factor: 4.792

2.  Vibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant in mice.

Authors:  Z Kossaczka; J Shiloach; V Johnson; D N Taylor; R A Finkelstein; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

3.  Pseudomonas aeruginosa injection decreases drainage in lateral neck dissection for metastatic thyroid cancer.

Authors:  Yu Ma; Cuifang Zeng; Ping Hou; Tao Wei; Jingqiang Zhu; Rixiang Gong; Zhihui Li
Journal:  Gland Surg       Date:  2020-10

4.  Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids.

Authors:  D N Taylor; A C Trofa; J Sadoff; C Chu; D Bryla; J Shiloach; D Cohen; S Ashkenazi; Y Lerman; W Egan
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

5.  Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines.

Authors:  S C Szu; D N Taylor; A C Trofa; J D Clements; J Shiloach; J C Sadoff; D A Bryla; J B Robbins
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

6.  Continuous high-cell-density fermentation of the ciliated protozoon Tetrahymena in a perfused bioreactor.

Authors:  T Kiy; A Tiedtke
Journal:  Appl Microbiol Biotechnol       Date:  1992-11       Impact factor: 4.813

7.  Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam.

Authors:  Z Kossaczka; F Y Lin; V A Ho; N T Thuy; P Van Bay; T C Thanh; H B Khiem; D D Trach; A Karpas; S Hunt; D A Bryla; R Schneerson; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.609

8.  Assessment of the impact of manufacturing changes on the physicochemical properties of the recombinant vaccine carrier ExoProtein A.

Authors:  Martin Burkhardt; Karine Reiter; Vu Nguyen; Motoshi Suzuki; Raul Herrera; Patrick E Duffy; Richard Shimp; Nicholas J MacDonald; L Renee Olano; David L Narum
Journal:  Vaccine       Date:  2018-09-24       Impact factor: 4.169

9.  Conjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: a strategy for enhancing immunogenicity of malaria vaccine candidates.

Authors:  Feng Qian; Yimin Wu; Olga Muratova; Hong Zhou; Gelu Dobrescu; Peter Duggan; Lambert Lynn; Guanhong Song; Yanling Zhang; Karine Reiter; Nicholas MacDonald; David L Narum; Carole A Long; Louis H Miller; Allan Saul; Gregory E D Mullen
Journal:  Vaccine       Date:  2007-03-13       Impact factor: 4.169

10.  Synthesis and some immunologic properties of an O-acetyl pectin [poly(1-->4)-alpha-D-GalpA]-protein conjugate as a vaccine for typhoid fever.

Authors:  S C Szu; S Bystricky; M Hinojosa-Ahumada; W Egan; J B Robbins
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.